跳至主要内容
临床试验/NCT06037447
NCT06037447招募中不适用

A Prospective Controlled Study for the Treatment Effect of Different Intervention Strategies for Pediatric Mitral Regurgitation--A Multicenter Prospective Cohort Study of Innovative Strategies for Mitral Valve Repair

China National Center for Cardiovascular Diseases1 个研究点 分布在 1 个国家目标入组 256 人开始时间: 2022年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
256
试验地点
1
主要终点
the recurrence rate of moderate to severe mitral valve regurgitation

研究概览

简要总结

The goal of this observational study is to compare the safety and effectiveness of a 3-steps standardized repair-oriented strategy with annuloplasty only in pediatric patients with mild to moderate mitral valve regurgitation.

The main questions it aims to answer are:

  • Can 3-steps standardized repair-oriented strategy improve both left ventricular and mitral valve function in pediatric patients with mild to moderate mitral valve regurgitation?
  • Can surgical complications caused by the 3-steps standardized repair-oriented strategy be non-inferior (clinically acceptable) to annuloplasty only? Participants will be assigned to either the Standardized Group (including subvalvular apparatus rehabilitation (leaflet plication if chordae absent on leaflet margin, mal-connected chordae resection if chordae mal-connected to leaflet body, papillary muscle splitting if short chordae or dysplastic or fused papillary muscle etc.), leaflets repair (leaflets plication if functional leaflet prolapse, leaflet cleft closure and patch augmentation for anatomical leaflet defect, etc.) and annuloplasty (posterior annuloplasty for annular dilatation and shallow leaflet coaptation, etc.)) or the Annuloplasty Group (annuloplasty only during mitral repair surgeries. Additionally, echocardiography, electrocardiograms, and measurements of N-terminal pro-brain natriuretic peptide (NT-proBNP) were conducted before the initiation of surgery and at 1 months, 3 months, and 6 months after mitral repair.

Researchers will compare the Standardized Group and the Annuloplasty Group to see if the recurrence rate of moderate to severe mitral valve regurgitation, as assessed by echocardiography after 6 months of surgery, is lower in the former than in the latter.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • < 14 years old
  • had not undertake mitral valve surgery before
  • moderate to severe mitral regurgitation

排除标准

  • moderate to severe mitral regurgitation which concommitant with other cardiac malformation which can not be correct or can only perform palliative surgery
  • concommitant with mitral stenosis
  • ischemic mitral regurgitation (for example, concommitant with anomalous origin of coronary artery)
  • Barlow syndrome
  • dysplasia of mitral leaflet
  • complete/Partial endocardial cushion defect
  • common atrioventricular valve
  • atrioventricular common channel
  • cardiomyopathy
  • other mitral valve surgery contraindications

结局指标

主要结局

the recurrence rate of moderate to severe mitral valve regurgitation

时间窗: after 6 months of surgery

During follow-up visits, echocardiographic examination is conducted to measure the degree of mitral valve regurgitation. If it falls within the moderate to severe range, it is recorded as a recurrence.

次要结局

  • NT-proBNP level(after 6 months of surgery)
  • Improvement in symptoms(after 6 months of surgery)
  • Change in left ventricular function(after 6 months of surgery)
  • Incidence rate of surgical complications(after 6 months of surgery)

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Shoujun Li

Director of Congenital Heart Surgery Center

China National Center for Cardiovascular Diseases

研究点 (1)

Loading locations...

相似试验

Study of Innovative Strategies for Mitral Valve... | 临床试验